MukoCell Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2.17M

  • Investors
  • 1

MukoCell General Information

Description

Developer of tissue-engineering products intended for the treatment of urologic disease. The company specializes in the manufacture, development, and sale of patient-made tissue replacements for the reconstruction of organs, thereby enabling physicians to provide an option of reconstructing the urethra with an autologous cell transplant.

Contact Information

Website
www.mukocell.com
Formerly Known As
UroTec
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • BioMedizinZentrum
  • Otto-Hahn-Street15
  • 44227 Dortmund
  • Germany
+49
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Parent Company
Apogepha
Vertical(s)
Life Sciences
Corporate Office
  • BioMedizinZentrum
  • Otto-Hahn-Street15
  • 44227 Dortmund
  • Germany
+49

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MukoCell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 18-Aug-2021 $2.17M Completed Generating Revenue
3. Merger/Acquisition 18-Sep-2010 Completed Generating Revenue
2. Early Stage VC 01-Jan-2009 Completed Product Development
1. Seed Round 01-Apr-2008 Completed Product Development
To view MukoCell’s complete valuation and funding history, request access »

MukoCell Patents

  • 17

    Total Documents Applications and Grants

  • Total Patents Families

  • 9

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

MukoCell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3985395-A1 Method for producing transplantable oral mucosa tissue Inactive 16-Oct-2020
EP-4229418-A1 Method for producing transplantable oral mucosa tissue Pending 16-Oct-2020
US-12582750-B2 Method for producing transplantable oral mucosa tissue Active 16-Oct-2020
US-20230414834-A1 Method for producing transplantable oral mucosa tissue Active 16-Oct-2020
WO-2022079312-A1 Method for producing transplantable oral mucosa tissue Inactive 16-Oct-2020 G01N33/6863
To view MukoCell’s complete patent history, request access »

MukoCell Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
CFH Management PE/Buyout Minority
FamiCord Corporation Minority
High-Tech Gründerfonds Venture Capital Minority
Saxony Development Bank Corporation Minority
Technologiegründerfonds Sachsen Venture Capital Minority
To view MukoCell’s complete investors history, request access »

Ready to get started?

Request a free trial

MukoCell FAQs

  • When was MukoCell founded?

    MukoCell was founded in 2005.

  • Where is MukoCell headquartered?

    MukoCell is headquartered in Dortmund, Germany.

  • What industry is MukoCell in?

    MukoCell’s primary industry is Pharmaceuticals.

  • Is MukoCell a private or public company?

    MukoCell is a Private company.

  • What is MukoCell’s current revenue?

    The current revenue for MukoCell is .

  • Who are MukoCell’s investors?

    CFH Management, FamiCord, High-Tech Gründerfonds, Saxony Development Bank, and Technologiegründerfonds Sachsen have invested in MukoCell.

  • When was MukoCell acquired?

    MukoCell was acquired on 18-Aug-2021.

  • Who acquired MukoCell?

    MukoCell was acquired by Apogepha.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process